Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023

Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging infectious diseases 2024-09, Vol.30 (9), p.1903-1906
Hauptverfasser:	Caméléna, François, Mérimèche, Manel, Brousseau, Julie, Mainardis, Mary, Verger, Pascale, Le Risbé, Caroll, Brottet, Elise, Thabuis, Alexandra, Bébéar, Cécile, Molina, Jean-Michel, Lot, Florence, Chazelle, Emilie, Berçot, Béatrice
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimicrobial agents antimicrobial resistance bacteria Bacterial infections Care and treatment Case studies Diagnosis Disease prevention Dispatch Drug resistance Drug-resistant Emergence of Extensively Drug-Resistant France, 2023 Genomes Gonorrhea Infections Mutation Neisseria gonorrhoeae Patients penA-60.001 Penicillin Public health Sexually transmitted diseases STD Surveillance Working groups
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as isolates from Cambodia.
ISSN:	1080-6040 1080-6059 1080-6059
DOI:	10.3201/eid3009.240557